Impact of Adipose Tissue Repartition on the Time Course of Vascular Dysfunction - the NUMEVOX Cohort

University Hospital, Angers

Status: Unknown

Conditions: Metabolic Diseases; Sleep Apnea; Atherosclerosis

Study type: Observational

Funder types: Other

Identifiers

NCT00997165

CHU-Promoteur 08-01

Details and patient eligibility

About

The NUMEVOX cohort is intended to follow-up the macro and microvascular dysfunction in relation to adipose tissue repartition in patients with metabolic syndrome associated to liver steatosis, sleep apnea. Duration of the follow-up is 3 years for each patient entering the cohort.

Enrollment: 500 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• informed consent
• age > 18 years old
• suspected of metabolic syndrome
• affiliated to french social health care

Exclusion criteria

• age < 18 years old
• pregnancy
• no informed consent
• not eligible for the study (no MS, cancer)

Trial design

500 participants in 3 patient groups

Metabolic syndrome (MS)

Description:

Patients suspected of metabolic syndrome without sleep apnea or liver steatosis

MS with sleep apnea

Description:

Metabolic syndrome with sleep apnea

MS with Liver steatosis

Description:

Metabolic syndrome with liver steatosis